Overall rank by patents
#25,160
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G09B (EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS).
The verdict
Simbionix holds 11 US patents across 11 technology areas, rank #25,160 of 50,000 tracked assignees.
Simbionix Ltd. has been granted 11 US utility patents between 2016 and 2025, placing Simbionix Ltd. at rank #25,160 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.9 claims per patent with primary concentration in G09B (EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS). As a Foreign Corporation, Simbionix Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Simbionix sits between SI Analytics Co., Ltd. (11 patents, rank #25,156) and SK Bioscience Co., Ltd. (11 patents, rank #25,164) - the closest US assignees by grant volume. The composite Innovation Score of 34.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Simbionix Ltd.'s 16.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Simbionix Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SI ANALYTICS CO., LTD.
11 patents
SIDEL PACKING SOLUTIONS
11 patents
SIGNA CHEMISTRY, INC.
11 patents
SIGNET GROUP SERVICES US INC.
11 patents
SINGAPORE TECHNOLOGIES AEROSPACE LTD
11 patents
SINGULEX, INC.
11 patents
SINOPSYS SURGICAL, INC.
11 patents
SK BIOSCIENCE CO., LTD.
11 patents
SIMBIONIX LTD.
11 patents
What this shows Simbionix holds 11 patents at rank #25,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Simbionix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2019 | 3 | 27.3% |
| 2020 | 1 | 9.1% |
| 2021 | 1 | 9.1% |
| 2022 | 2 | 18.2% |
| 2023 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Top 11 of 11 technology areas
Overall rank by patents
#25,160
Across all tracked assignees
34.5 out of 100
How to use this portfolio
Simbionix's 11 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.